113 related articles for article (PubMed ID: 16225076)
1. Cytogenetic aspects of buprenorphine maintenance treatment program--preliminary report.
Piatek P; Pach D; Kamenczak A; Schmager J
Przegl Lek; 2005; 62(6):391-3. PubMed ID: 16225076
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of methadone maintenance treatment program on the frequency of DNA lesions revealed as micronuclei and sister chromatid exchanges.
Furtak S; Pach D; Chrostek Maj J; Schmager J
Przegl Lek; 2005; 62(6):387-90. PubMed ID: 16225075
[TBL] [Abstract][Full Text] [Related]
3. [Micronuclei as markers of DNA damage in patients addicted to opioid drugs].
SkowroĊska A; Groszek B; Schmager J
Przegl Lek; 2004; 61(4):241-3. PubMed ID: 15521574
[TBL] [Abstract][Full Text] [Related]
4. Managing opioid dependence. Comparing buprenorphine with methadone.
Cavacuiti C; Selby P
Can Fam Physician; 2003 Jul; 49():876-7. PubMed ID: 12901482
[No Abstract] [Full Text] [Related]
5. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
Bell J; Mutch C
Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
[TBL] [Abstract][Full Text] [Related]
6. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care.
Goodman D
J Midwifery Womens Health; 2011; 56(3):240-7. PubMed ID: 21535372
[TBL] [Abstract][Full Text] [Related]
8. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
9. Exposure to opioid maintenance treatment reduces long-term mortality.
Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
Lintzeris N; Mitchell TB; Bond AJ; Nestor L; Strang J
Drug Alcohol Depend; 2007 Dec; 91(2-3):187-94. PubMed ID: 17624687
[TBL] [Abstract][Full Text] [Related]
11. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
[TBL] [Abstract][Full Text] [Related]
12. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
14. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Loeber S; Kniest A; Diehl A; Mann K; Croissant B
Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
[TBL] [Abstract][Full Text] [Related]
16. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
Soyka M; Apelt SM; Lieb M; Wittchen HU
J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
18. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine for opioid dependence.
Milne M; Crouch BI; Caravati EM
J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
